The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
<p>Abstract</p> <p>Background</p> <p>The incidence of gout rises with increasing age. Management of elderly (≥65 years) gout patients can be challenging due to high rates of comorbidities, such as renal impairment and cardiovascular disease, and concomitant medication u...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-03-01
|
| Series: | BMC Geriatrics |
| Online Access: | http://www.biomedcentral.com/1471-2318/12/11 |